Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-25-020550
Filing Date
2025-07-30
Accepted
2025-07-30 16:02:54
Documents
2
Period of Report
2025-07-17

Document Format Files

Seq Description Document Type Size
1 form3-07302025_080751.html 3  
1 form3-07302025_080751.xml 3 1694
2 ex24-07302025_080751.htm EX-24 5094
  Complete submission text file 0001415889-25-020550.txt   8271
Mailing Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140
Business Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140 617-655-6580
Vor Biopharma Inc. (Issuer) CIK: 0001817229 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O VOR BIOPHARMA INC. 100 CAMBRIDGEPARK DRIVE, SUITE 101 CAMBRIDGE MA 02140
Business Address
Zuraw Qing Che (Reporting) CIK: 0002079210 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39979 | Film No.: 251166909